(Q34384879)

1 August 2017

title

Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry (English)

1 reference

1 August 2017

1 reference

Roberts F

1

1 reference

1 August 2017

McCall AE

series ordinal

2

1 reference

1 August 2017

Burnett RA

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Journal of Clinical Pathology

1 August 2017

published in

1 reference

1 August 2017

volume

54

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

766-770

1 reference

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

The immunohistochemical diagnosis of epithelial mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

Pathology of malignant mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731284

Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura

27 October 2018

1 reference

12 December 2020

Diffuse malignant pleural mesothelioma in glasglow

1 reference

12 December 2020

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma

1 reference

12 December 2020

The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies

1 reference

12 December 2020

The Immunohistochemical Diagnostic Panel for Epithelial Mesothelioma

1 reference

12 December 2020

Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis

1 reference

12 December 2020

Immunohistochemical detection of p53--effect of fixation and methods of antigen retrieval

1 reference

12 December 2020

HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.54.10.766

1 reference

1 August 2017

1 reference

1 August 2017

1 reference